T. Ohki et al., ENDOVASCULAR AORTOUNIFEMORAL GRAFTS AND FEMOROFEMORAL BYPASS FOR BILATERAL LIMB-THREATENING ISCHEMIA, Journal of vascular surgery, 24(6), 1996, pp. 984-996
Purpose: Although axillobifemoral bypass procedures have a lower morta
lity rate than aortobifemoral bypass procedures, they are limited by d
ecreased patency moderate hemodynamic improvement, and the need for ge
neral anesthesia. This report describes an alternative approach to bil
ateral aortoiliac occlusive disease using unilateral endovascular nort
ofemoral bypass procedures in combination with standard femorofemoral
reconstructions. Methods: Seven patients who had bilateral critical is
chemia and tissue necrosis in association with severe comorbid medical
illnesses underwent implantation of unilateral aortofemoral endovascu
lar grafts, which were inserted into predilated, recanalized iliac art
eries. The proximal end of the endovascular graft was fixed to the dis
tal aorta or common iliac artery with a Palmaz stent. The distal end o
f the graft was suture-anastomosed to the ipsilateral patent outflow v
essel, and a femorofemoral bypass procedure was then performed. Result
s: All endovascular grafts were successfully inserted through five occ
luded and two diffusely stenotic iliac arteries under either local (1)
, epidural (5), or general anesthesia (1). The mean thigh pulse volume
recording amplitudes increased from 9+/-3 mm to 30+/-7 mm and from 6/-2 mm to 26+/-4 mm ipsilateral and contralateral to the aortofemoral
graft insertion, respectively. In all cases the symptoms completely re
solved. procedural complications were limited to one local wound hemat
oma. No graft thromboses occurred during follow-up to 28 months (mean,
17 months). Conclusions: Endovascular iliac grafts in combination wit
h standard femorofemoral bypass grafts may be an effective alternative
to axillobifemoral bypass in high-risk patients who have diffuse aort
oiliac occlusive disease, particularly when bilateral axillary-subclav
ian disease is present.